Increase/Decrease in Cash: The total change in cash for the company over the given period.
ADARx Pharmaceuticals, Inc. (ADRX) had Increase/Decrease in Cash of $504.09M for the most recently reported fiscal quarter, ending 2026-09-30.
| Income Statement Financials | |
$2.22M |
|
$-28.12M |
|
-- |
|
$2.22M |
|
$34.39M |
|
$-32.18M |
|
$4.06M |
|
$-28.12M |
|
$-28.12M |
|
$-28.12M |
|
$-28.12M |
|
$-28.12M |
|
$-28.12M |
|
$-32.18M |
|
$-32.18M |
|
16.13M |
|
16.13M |
|
$-1.74 |
|
$-1.74 |
|
| Balance Sheet Financials | |
$918.51M |
|
$4.40M |
|
$10.55M |
|
$929.06M |
|
$43.57M |
|
-- |
|
$311.09M |
|
$354.66M |
|
$574.40M |
|
$574.40M |
|
$574.40M |
|
107.26M |
|
| Cash Flow Statement Financials | |
$-76.75M |
|
$78.61M |
|
$502.10M |
|
$66.52M |
|
$570.61M |
|
|
Increase/Decrease in Cash |
$504.09M |
$4.27M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|